chr1-196779209-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_021023.6(CFHR3):c.106G>T(p.Glu36Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000215 in 1,393,010 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 25)
Exomes 𝑓: 0.0000022 ( 0 hom. )
Consequence
CFHR3
NM_021023.6 stop_gained
NM_021023.6 stop_gained
Scores
3
4
Clinical Significance
Conservation
PhyloP100: 4.03
Genes affected
CFHR3 (HGNC:16980): (complement factor H related 3) The protein encoded by this gene is a secreted protein, which belongs to the complement factor H-related protein family. It binds to heparin, and may be involved in complement regulation. Mutations in this gene are associated with decreased risk of age-related macular degeneration, and with an increased risk of atypical hemolytic-uremic syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR3 | NM_021023.6 | c.106G>T | p.Glu36Ter | stop_gained | 2/6 | ENST00000367425.9 | |
CFHR3 | NM_001166624.2 | c.106G>T | p.Glu36Ter | stop_gained | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR3 | ENST00000367425.9 | c.106G>T | p.Glu36Ter | stop_gained | 2/6 | 1 | NM_021023.6 | P1 | |
CFHR3 | ENST00000471440.6 | c.106G>T | p.Glu36Ter | stop_gained | 2/5 | 1 | |||
CFHR3 | ENST00000391985.7 | c.106G>T | p.Glu36Ter | stop_gained | 2/5 | 2 | |||
CFHR3 | ENST00000367427.7 | c.106G>T | p.Glu36Ter | stop_gained, NMD_transcript_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD3 genomes
Cov.:
25
GnomAD3 exomes AF: 0.00000420 AC: 1AN: 238176Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 128418
GnomAD3 exomes
AF:
AC:
1
AN:
238176
Hom.:
AF XY:
AC XY:
0
AN XY:
128418
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000215 AC: 3AN: 1393010Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 691760
GnomAD4 exome
AF:
AC:
3
AN:
1393010
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
691760
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 25
GnomAD4 genome
Cov.:
25
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 25, 2022 | Variant summary: CFHR3 c.106G>T (p.Glu36X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay. Other truncations within this gene have been classified as variants of uncertain significance internally and in ClinVar. The variant allele was found at a frequency of 4.2e-06 in 238176 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.106G>T in individuals affected with Genetic Atypical Hemolytic Uremic Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
A;A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -47
Find out detailed SpliceAI scores and Pangolin per-transcript scores at